Novel bone-targeting agents in prostate cancer. - Wikidata - wikimedia - TriplyDB

Novel bone-targeting agents in prostate cancer.

Novel bone-targeting agents in prostate cancer.

http://www.wikidata.org/entity/Q38198934

about

Endothelin The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.

P2860

Q26767156-9034B34F-F73A-4531-A508-07B14DEDB2C8 Q41200607-42696EDE-7DE8-470C-85DF-3255486C7052

P2860

Novel bone-targeting agents in prostate cancer.

http://www.wikidata.org/entity/Q38198934

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel bone-targeting agents in prostate cancer.

@en

type

label

Novel bone-targeting agents in prostate cancer.

@en

prefLabel

Novel bone-targeting agents in prostate cancer.

@en

P1433

Q38198934-4A9B4349-74F0-405B-A75E-A8F65271CB82

P1476

Q38198934-EAEFFA5C-AED5-4ABF-B77E-03873EA870B0

P2093

Q38198934-4EE7F540-E487-4216-A292-BF815F713A8F

Q38198934-7B21EEA4-9004-4218-80AE-26F69BB8C71B

P2860

Q38198934-04858693-E95C-4C61-94B1-7F22ECA61661

Q38198934-04E8B198-2897-4489-BA86-52A0DAB84AFD

Q38198934-0547E61B-0C07-4D54-8559-C2627FCBEA91

Q38198934-0EAC4874-658F-4B1E-894D-7E7863F50D71

Q38198934-11040ED7-020F-46F6-BA24-54C63E0BCA14

Q38198934-173E99F3-3DF4-48AB-B803-A0E16ADC5B8E

Q38198934-1FA313FA-8B55-40FE-8556-875356F03BDA

Q38198934-23B0B21F-165E-478A-B26E-9105BBD1B631

Q38198934-24B9C0A0-41E0-40C7-9ECF-00F2D57DDAFE

Q38198934-256483BB-ACAB-4195-AFD1-C2CDBFF71271

P2888

Q38198934-D9DC3AE2-6B85-4D72-89BE-8367CF975DB3

P304

Q38198934-1BBF7399-ED9C-46B2-8F47-37BF44C3BFF3

P31

Q38198934-625F3AF7-9D07-401C-BAAB-73C68685A428

P356

Q38198934-6E2B10F1-F6B2-4B17-92B3-6BB1A0D06E09

P433

Q38198934-CBBA5EDC-F371-41BB-BDA3-07AB1805D0E8

P478

Q38198934-F5DF88E6-9F9C-43A6-B771-C403CCB5C368

P577

Q38198934-340D589E-2F51-4ABC-A970-0571E8B3F266

P698

Q38198934-E7D5F78C-BFC4-4F1A-9B6F-025A8620EBED

P356

P1433

Prostate Cancer and Prostatic Diseases

P1476

Novel bone-targeting agents in prostate cancer.

@en

P2093

C Albany

http://www.w3.org/2001/XMLSchema#string

N M Hahn

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Skeletal remodeling in health and disease

Radioisotopes for the palliation of metastatic bone cancer: a systematic review

Osteoclast differentiation and activation

Alpha emitter radium-223 and survival in metastatic prostate cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Molecular mechanisms and treatment of bone metastasis.

P2888

P304

112-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PCAN.2014.12

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24662963

http://www.w3.org/2001/XMLSchema#string